亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Alzheimer Detection System

详细技术说明
Retinal Scan Detects Alzheimer’sAn imaging device based on the variable near infrared (VNIR) Hyperspectral Imaging (HSI) system can be used for early detection of Alzheimer’s disease (AD). The device combines conventional imaging with spectrophotometry to create pixel-level spectral quantification of a sample. The HSI system is non-invasive; imaging samples are obtained through a simple retinal scan that doesn’t require any dyes or additional reagents.Detection Before Amyloid-beta AggregationPrior to cognitive symptoms of AD, plaques form in the brain from amyloid-beta (Aβ) peptides, an event known as Aβ aggregation. In vitro assessment with this new imaging system detected cellular cytoplasmic changes before Aβ aggregation. In mouse tests, AD was detected 25% sooner than visible plaque formation. This is the only existing diagnostic method that can detect AD before Aβ plaque formation.Potential ApplicationsThe efficacy of current AD treatments is severely limited by the lack of an early diagnostic method. Presently, patients can only be diagnosed with AD after visible plaques have formed in their brains. At this point, treatments can only slow down the inevitable progression of cognitive symptoms. With the new HSI system, a physician could make an AD diagnosis long before visible plaques formed in the patient’s brain. This would enable the patient to begin treatment significantly sooner, improving their prognosis.Additionally, the HSI system could be used to determine the success of AD treatments by measuring cellular changes and levels of Aβ aggregation. This would enable physicians to fine-tune treatments to better suit the patient’s needs.BENEFITS AND FEATURES OF EARLY ALZHEIMER’S DETECTION IMAGING SYSTEM:Non-invasiveFirst diagnostic method to detect AD before visible plaque formationCould be used to assess and tailor AD treatmentsCreates pixel-level quantificationIntegrates different imaging systemsPhase of Development In vitro assessment data and in vivo efficacy data available
*Abstract
None
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备